The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 20, 2016

Filed:

Jul. 29, 2011
Applicants:

James C. Paulson, Del Mar, CA (US);

Matthew Macauley, San Diego, CA (US);

David Nemazee, San Diego, CA (US);

Inventors:

James C. Paulson, Del Mar, CA (US);

Matthew Macauley, San Diego, CA (US);

David Nemazee, San Diego, CA (US);

Assignee:

The Scripps Research Institute, La Jolla, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/385 (2006.01); A61K 9/127 (2006.01); A61K 39/00 (2006.01); A61K 39/35 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
A61K 39/385 (2013.01); A61K 9/127 (2013.01); A61K 39/001 (2013.01); A61K 39/35 (2013.01); A61K 47/48815 (2013.01); A61K 2039/55555 (2013.01);
Abstract

The present invention provides liposomal compositions for inducing immune tolerance. The compounds typically comprise a liposome displaying a specific antigen and also a binding moiety for a sialic acid binding Ig-like lectin (Siglec)expressed on B cells. The invention also provides methods for inducing tolerance to a protein or polypeptide antigen (e.g., a protein antigen) in a subject. The methods involve administering to the subject a pharmaceutical composition that co-presents both the antigen and a glycan ligand for a Siglec expressed on B lymphocytes.


Find Patent Forward Citations

Loading…